81282-82-8

Basic information

• Product Name: 4-(3,5-DIMETHYL-PYRAZOL-1-YL)-BENZOIC ACID
• Synonyms: TIMTEC-BB SBB004438;OTAVA-BB BB7110950792;4-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZOIC ACID;4-(3,5-DIMETHYL-PYRAZOL-1-YL)-BENZOIC ACID;AKOS BBS-00000230;CHEMBRDG-BB 4400389;IFLAB-BB F1930-0020;4-(3,5-dimethyl-1H-pyrazol-1-yl)benzoic acid(SALTDATA: FREE)
• CAS NO: 81282-82-8
• Molecular Formula: C₁₂H₁₂N₂O₂
• Molecular Weight: 216.24
• Product Categories: Carboxylic Acids;Phenyls & Phenyl-Het;Carboxylic Acids;Phenyls & Phenyl-Het
• Mol File: 81282-82-8.mol
• Article Data: 9

Chemical Properties

• Melting Point: 163 °C
• Boiling Point: 381.8 °C at 760 mmHg
• Flash Point: 184.7 °C
• Appearance: /
• Density: 1.22 g/cm³
• Vapor Pressure: 1.64E-06mmHg at 25°C
• Refractive Index: 1.606
• Storage Temp.: 2-8°C
• PKA: 3.83±0.10(Predicted)
• CAS DataBase Reference: 4-(3,5-DIMETHYL-PYRAZOL-1-YL)-BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3,5-DIMETHYL-PYRAZOL-1-YL)-BENZOIC ACID(81282-82-8)
• EPA Substance Registry System: 4-(3,5-DIMETHYL-PYRAZOL-1-YL)-BENZOIC ACID(81282-82-8)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 81282-82-8(Hazardous Substances Data)

Usage

General Description

4-(3,5-DIMETHYL-PYRAZOL-1-YL)-BENZOIC ACID is a chemical compound with the molecular formula C13H14N2O2. It is a derivative of benzoic acid and is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. 4-(3,5-DIMETHYL-PYRAZOL-1-YL)-BENZOIC ACID has been found to exhibit anti-inflammatory and anti-tumor activities, making it a potentially valuable ingredient in the development of new drugs. It is also used in research and development in the fields of medicine and biology due to its diverse and powerful chemical properties.

InChI:InChI=1/C12H12N2O2/c1-8-7-9(2)14(13-8)11-5-3-10(4-6-11)12(15)16/h3-7H,1-2H3,(H,15,16)

Upstream product

• 24589-77-3 4-hydrazinobenzoic acid hydrochloride 
• 123-54-6 acetylacetone 
• 619-67-0 4-Hydrazinobenzoic acid 

Downstream Products

• 1236055-25-6 6-(4-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl)-3-(naphthalen-1-ylmethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole 
• 1236055-24-5 6-(4-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl)-3-phenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole 
• 1236055-26-7 3-(2-chlorophenyl)-6-(4-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole 
• 86618-73-7 4-(3,5-dimethyl-1H-pyrazol-1-yl)benzoyl chloride 
• 81282-72-6 4-(3,5-Dimethyl-pyrazol-1-yl)-benzoic acid 2-(2-bromo-acetyl)-phenyl ester 
• 81282-80-6 2-[4-(3,5-Dimethyl-pyrazol-1-yl)-benzoyl]-benzofuran-3-one 
• 86618-69-1 C₄₄H₃₈N₆O₇ 
• 86618-68-0 4-(3,5-Dimethyl-pyrazol-1-yl)-benzoic acid 4-{3-[4-(3,5-dimethyl-pyrazol-1-yl)-phenyl]-3-oxo-propionyl}-3-hydroxy-phenyl ester 
• 81282-76-0 1-[4-(3,5-Dimethyl-pyrazol-1-yl)-phenyl]-3-(2-hydroxy-phenyl)-propane-1,3-dione 
• 81282-68-0 2-<4-(3,5-dimethyl-1(H)-pyrazole)benzoyloxy>acetophenone 
• 86618-67-9 2,4,6-tri-<4-(3,5-dimethyl-1(H)-pyrazole)benzoyloxy>acetophenone 
• 86618-66-8 2,4-di-<4-(3,5-dimethyl-1(H)-pyrazole)benzoyloxy>acetophenone 

Relevant articles and documents

Design, synthesis and anticandidal evaluation of indazole and pyrazole derivatives

Candidiasis, caused by yeasts of the genus Candida, is the second cause of superficial and mucosal infections and the fourth cause of bloodstream infections. Although some antifungal drugs to treat candidiasis are available, resistant strains to current therapies are emerging. Therefore, the search for new candicidal compounds is certainly a priority. In this regard, a series of indazole and pyrazole derivatives were designed in this work, employing bioisosteric replacement, homologa-tion, and molecular simplification as new anticandidal agents. Compounds were synthesized and evaluated against C. albicans, C. glabrata, and C. tropicalis strains. The series of 3-phenyl-1H-indazole moiety (10a–i) demonstrated to have the best broad anticandidal activity. Particularly, compound 10g, with N,N-diethylcarboxamide substituent, was the most active against C. albicans and both miconazole susceptible and resistant C. glabrata species. Therefore, the 3-phenyl-1H-indazole scaf-fold represents an opportunity for the development of new anticandidal agents with a new chemo-type.

KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE

Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.

Sulfamic acid (H2NSO3H): A low-cost, mild, and efficient catalyst for the synthesis of substituted N-Phenylpyrazoles under solvent-free conditions

N-Phenylpyrazoles are synthesized by condensing phenylhydrazine and 1,3-diketones in the presence of a catalytic amount of sulfamic acid, a mild and an efficient solid acid catalyst, under solvent-free conditions. This condensation proceeds smoothly in shorter reaction time. Copyright Taylor & Francis Group, LLC.